In the world of speculative biotech, one company that is clearly on the cutting edge is Advanced Cell Technology (ACTC.OB). This biotechnology company is focused on the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. In terms of ongoing clinical trials, the company's main focus revolves around its three macular degeneration trials, two in the U.S. and one in Europe.
As with any small biotech company, like ACT, it takes a great amount of time and research to get enough meaningful data to see if one should invest. Reading SEC filings, listening to conference calls, and viewing corporate presentations provides a great deal of insight, but that is not enough. Sometimes...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|